Literature DB >> 25873594

Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction.

Peter S Hasenhuetl1, Klaus Schicker1, Xaver Koenig1, Yang Li1, Subhodeep Sarker1, Thomas Stockner1, Sonja Sucic1, Harald H Sitte1, Michael Freissmuth1, Walter Sandtner2.   

Abstract

The membrane transporters for the monoamines serotonin (SERT) and dopamine (DAT) are prominent targets of various psychoactive substances, including competitive inhibitors, such as tricyclic antidepressants, methylphenidate, and cocaine. Upon rapid application of a substrate, SERT and DAT display an inwardly directed current comprised of a peak and a steady-state component. Binding of a competitive inhibitor to the transporter leads to reduction of the peak current amplitude because occupancy of the transporter by an inhibitor prevents the induction of the peak current by the substrate. We show that the inhibitory effect on the peak current can be used to study the association rate constant (k(on)), dissociation rate constant (k(off)), and equilibrium dissociation constant (K(D)) of chemically distinct SERT and DAT inhibitors, with high temporal precision and without the need of high-affinity radioligands as surrogates. We exemplify our approach by measuring the kinetics of cocaine, methylphenidate, and desipramine binding to SERT and DAT. Our analysis revealed that the selectivity of methylphenidate and desipramine for DAT and SERT, respectively, can be accounted for by their rate of association and not by the residence time in their respective binding sites.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25873594     DOI: 10.1124/mol.115.099036

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  The rate of dasotraline brain entry is slow following intravenous administration.

Authors:  Robert Lew; Cristian C Constantinescu; Daniel Holden; Richard E Carson; Vincent Carroll; Gerald Galluppi; Kenneth S Koblan; Seth C Hopkins
Journal:  Psychopharmacology (Berl)       Date:  2020-08-19       Impact factor: 4.530

2.  Structural insights into GABA transport inhibition using an engineered neurotransmitter transporter.

Authors:  Deepthi Joseph; Smruti Ranjan Nayak; Aravind Penmatsa
Journal:  EMBO J       Date:  2022-07-07       Impact factor: 14.012

3.  Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters.

Authors:  Walter Sandtner; Thomas Stockner; Peter S Hasenhuetl; John S Partilla; Amir Seddik; Yuan-Wei Zhang; Jianjing Cao; Marion Holy; Thomas Steinkellner; Gary Rudnick; Michael H Baumann; Gerhard F Ecker; Amy Hauck Newman; Harald H Sitte
Journal:  Mol Pharmacol       Date:  2015-10-30       Impact factor: 4.436

4.  Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates.

Authors:  Shreyas Bhat; Peter S Hasenhuetl; Ameya Kasture; Ali El-Kasaby; Michael H Baumann; Bruce E Blough; Sonja Sucic; Walter Sandtner; Michael Freissmuth
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

5.  The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.

Authors:  Carina Kern; Fatma Asli Erdem; Ali El-Kasaby; Walter Sandtner; Michael Freissmuth; Sonja Sucic
Journal:  J Biol Chem       Date:  2017-01-19       Impact factor: 5.157

6.  Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.

Authors:  Jacob Andersen; Kristoffer B Ringsted; Benny Bang-Andersen; Kristian Strømgaard; Anders S Kristensen
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

7.  Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter.

Authors:  Yang Li; Peter S Hasenhuetl; Klaus Schicker; Harald H Sitte; Michael Freissmuth; Walter Sandtner
Journal:  J Biol Chem       Date:  2015-10-26       Impact factor: 5.157

8.  Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter.

Authors:  Peter S Hasenhuetl; Michael Freissmuth; Walter Sandtner
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

9.  Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism.

Authors:  Yang Li; Felix P Mayer; Peter S Hasenhuetl; Verena Burtscher; Klaus Schicker; Harald H Sitte; Michael Freissmuth; Walter Sandtner
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.486

10.  A label-free approach to detect ligand binding to cell surface proteins in real time.

Authors:  Verena Burtscher; Matej Hotka; Yang Li; Michael Freissmuth; Walter Sandtner
Journal:  Elife       Date:  2018-04-26       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.